Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Ojemda
.
Show all posts
Showing posts with label
Ojemda
.
Show all posts
Saturday, September 28, 2024
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma
›
Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to deve...
›
Home
View web version
